Drug | Drug Class | Mechanism of Action | Adverse Effects | Nursing Implications |
heparin | #1. ________ | Inactivates clotting factors thrombin and factor Xa through the increased activity of antithrombin | Critical adverse effect:
#2. __________________
**Critical Allergic reaction** #3. _____________
|
Monitor(labs): #4. ____________
Reversal/antidote: #5. _____________ Administered Route: #6. (2 answers)_______________
|
Apixaban (Eliquis) | Anticoagulant | inhibits platelet aggregation (factor Xa) induced by thrombin. | Critical adverse effect:
#7. ________________
|
1. Increased risk of hemorrhage in pregnant patients
2. Increased risk of bleeding in patients with renal impairment |
Warfarin (Coumadin) | #8. ___________ | Decreases the production of vitamin K-dependent clotting factors. (Vit K synthesis) | · bruising
· ____#9_______ (after long term use)
|
Monitor(labs): INR (2-3 is normal)
Reversal/antidote: #10. ____________
Nursing Implications: Avoid in pregnancy or breast feeding Frequent monitoring of PT and INR |
enoxaparin (Lovenox) | anticoagulant | #11. _____________ | · Critical adverse effect is hemorrhage
· Critical allergic: · #12 ________ (induced by**hint)
|
Monitor(labs): #13 __________
Antidote: #14 _______________
|
fondaparinux | #15 ______________ | #16 ______________ | 1. Can cause epidural bleeds.
|
Labs to monitor: None
Nursing Implications: · Avoid giving in patients with decrease level of consciousness, complains of back pain or is paralyzed. · Do not administer to patients for at least 6 hours after #17_______or with a #18__________ epidural
|
Rivaroxaban (Xarelto)
Apixiban (Eliquis) Edoxanban (Savaysa) |
Anticoagulants | Inhibits factor Xa | Risk for neurological impairment | Lab monitoring: No routine clot studies
Nursing Implications: · Avoid over the counter medications (Vit E, ginkgo biloba, fish oils, garlic, NSAIDS)
· Teach patients to avoid bleeding by doing the following: (3 examples)___#19______
|
Drug | Drug Class | Mechanism of Action | Adverse Effects | Nursing Implications |
Aspirin (Acetylsalicylic Acid)
Indication: Reduce risk of CVA, TIA, prevent of MI
Treatment during episodes of unstable angina and MI
Prevention: occlusion of stents |
#20. __________ | Decrease platelet aggregation | Side effect:
· #21_________(given in high doses) · Bruising · Gastric upset
Adverse reaction: · GI bleed · hemorrhagic stroke (uncontrolled HTN)
|
Monitor(labs): platelets
Antidote for ASA toxicity: #22 _______(There are 2 optional answers that will be accepted.
Monitor for signs of: ***toxicity – tinnitus, hyperventilation,
|
Clopidogrel (Plavix) | Antiplatelet | #23 _________ | Side effect:
· diarrhea · gastric discomfort
Adverse Reaction: · bleeding · #24 ________ |
Monitor (labs):
#25 __________ Administered: po
|
Abciximab
Indicated: after cardiac procedures |
Antiplatelet
(Glycoprotein (GP) receptor inhibitors) |
Blocks GP IIB/IIIa receptors that stop platelet aggregation
|
Critical adverse reaction: · hemorrhage · Thrombocytopenia
|
Monitor: hgb & Platelets
***Assess for bleeding in 1. #26 _____ 2. #27_______ 3. IV insertion sites Nursing Implications 4. ECG changes 5. No needle sticks or new IV injections |
Drug | Drug Class | Mechanism of Action | Adverse Effects | Nursing Implications | ||||
tPA Alteplase Streptokinase
|
Thrombolytics | Break down, or lyse or existing clots | 1. Bleeding
Severe Effect: 1. Severe bleeding
|
Administered: #28 _(route)_ ONLY
Nursing Implications: 1. Monitor for mental status changes 2. No new IV, ABGS 3. Never give through a (route) #29 _________. 4. Do not give within 2 weeks of surgery 5. Do not give to patients with active #30 _______ 6. Can only be administered from #31______ hours from onset of symptoms 7. Monitor for cardiac changes/dysrhythmias 8. Uncontrolled hypertension or b/p (180/110)
|
||||
Drug | Drug Class | Mechanism of Action | Adverse Effects | Nursing Implications | ||||
Erythropoietin Alfa | Hematopoietic Agents | #32_____________ | · #33 ________
· Cardiovascular events- MI, CVA, DVT |
Monitor (labs):
#34 _____ & _______ ***Iron levels- key ingredient with the production of RBCs Nurse Implications: 1. Monitor: #35 (hint: which main vital sign) during therapy 2. Do not administer if hemoglobin 10-11 |
||||
Filgrastim
Indicated for Neutropenia |
Hematopoietic Agents | Increase production of neutrophils (in the bone marrow) | · Enlarge spleen
· __#36___ pain · Leukocytosis |
Monitor baseline (labs):
CBC and platelet counts Administered: IV & subQ |
||||
Oprelvekin | Hematopoietic Agents | Simulate platelet production | · #37_______ (sign of fluid overload)
· anemia · Cardiac dysrhythmias Severe Reaction: · Anaphylaxis |
Administered: #38 _____
Monitor (labs): platelet counts, electrolyte status Nursing Implications: · Fluid retention: Teach patient to contact provider if symptoms worsen. · Use with caution in patients with cardiac history- a-fib, a-flutter
|
||||
Iron Sulfate
Iron deficiency anemia, dietary supplement (prevention) |
Hematinic Agents
|
Replacement of iron which is critical for hemoglobin function | Adverse Reaction
· #39_______** · Nausea · Dark Tarry stools
Serious Side effect with IV route: #40_______
|
Patient Teaching
1. Take with vitamin #41_______ source.
2. Infusion: Give a test dose when administering #42 (which route). Keep epinephrine on h and for anaphylaxis. 3. Teach patient to increase fiber and drink plenty of fluids to reduce constipation
|
Folic Acid
Indicated: Folic acid anemia, dietary supplement
|
Hematinic Agents
|
Replacement for folic acid | 1. Nausea
2. Flatulence 3. Rash |
1. Teach patient dietary/lifestyle changes:
– Increase consumption of foods high in #43_______ (e.g., green vegetables, liver). 2. If alcoholism underlies dietary deficiency, offer counseling for alcoholism, as well as dietary advice. “ |
Vitamin B12
|
Hematinic Agents
|
Replacement Vitamin B12 anemia,
Dietary supplement, absence of intrinsic factor |
1. Headache
2. Nausea
Serious Adverse Reaction 1. #44________** (low lab value) 2. Pulmonary edema 3. Anaphylaxis |
1. Labs to Monitor: ***Serum ___#45___
Teach patient s/s of hypokalemia and instruct them to contact provider immediate. 2. Treatment duration- is #46 (how long) |
Answer Sheet
**Make sure you read the instructions.
- You must turn BOTH documents in to receive full credit. NO EXCEPTIONS.
- Provide your answers in the correct order. Make sure your numbers match what is given, or it will be marked incorrect.
- There is only one answer per blank. If the question indications there is more than one answer, then you must have all correct to receive credit.
- **You do not have to use this specific format. As long as you submit the answers in the correct order it will be accepted. However, if you decide to use this format, make sure the answer matches and form it is NEAT. Written answers will be accepted as long as they are in a pdf form so they can be read and graded.
1.
2.
3.
4.
5.
- (2 answers)
7.
8.
9.
10
11
12.
13.
14.
15.
16.
17.
18.
- (3) answers
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
________________________________________________________________________________________________________________
31.
32.
33.
- (2 answers)
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.